A live attenuated vaccine prevents replication and transmission of H7N9 highly pathogenic influenza viruses in mammals

Abstract H7N9 influenza viruses emerged in 2013 and have caused severe disease and deaths in humans in China. Some H7N9 viruses circulating in chickens have mutated to highly pathogenic viruses that have caused several disease outbreaks in chickens. Studies have shown that when the H7N9 highly patho...

Full description

Bibliographic Details
Main Authors: Wenyu Yang, Xin Yin, Lizheng Guan, Mei Li, Shujie Ma, Jianzhong Shi, Guohua Deng, Yasuo Suzuki, Hualan Chen
Format: Article
Language:English
Published: Taylor & Francis Group 2018-09-01
Series:Emerging Microbes and Infections
Online Access:http://link.springer.com/article/10.1038/s41426-018-0154-6
_version_ 1818534700670517248
author Wenyu Yang
Xin Yin
Lizheng Guan
Mei Li
Shujie Ma
Jianzhong Shi
Guohua Deng
Yasuo Suzuki
Hualan Chen
author_facet Wenyu Yang
Xin Yin
Lizheng Guan
Mei Li
Shujie Ma
Jianzhong Shi
Guohua Deng
Yasuo Suzuki
Hualan Chen
author_sort Wenyu Yang
collection DOAJ
description Abstract H7N9 influenza viruses emerged in 2013 and have caused severe disease and deaths in humans in China. Some H7N9 viruses circulating in chickens have mutated to highly pathogenic viruses that have caused several disease outbreaks in chickens. Studies have shown that when the H7N9 highly pathogenic viruses replicate in ferrets or humans, they easily acquire certain mammalian-adapting mutations and become highly lethal in mice and highly transmissible in ferrets by respiratory droplet, creating the potential for human-to-human transmission. Therefore, the development of effective control measures is a top priority for H7N9 pandemic preparedness. In this study, we evaluated the protective efficacy of a cold-adapted, live attenuated H7N9 vaccine (H7N9/AAca) against two heterologous H7N9 highly pathogenic viruses in mice and guinea pigs. Our results showed that one dose of the H7N9/AAca vaccine prevented disease and death in mice challenged with two different H7N9 highly pathogenic viruses, but did not prevent replication of the challenge viruses; after two doses of H7N9/AAca, the mice were completely protected from challenge with A/chicken/Hunan/S1220/2017(H7N9) virus, and very low viral titers were detected in mice challenged with H7N9 virus CK/SD008-PB2/627 K. More importantly, we found that one dose of H7N9/AAca could efficiently prevent transmission of CK/SD008-PB2/627 K in guinea pigs. Our study suggests that H7N9/AAca has the potential to be an effective H7N9 vaccine and should be evaluated in humans.
first_indexed 2024-12-11T18:14:58Z
format Article
id doaj.art-0bdfa9fd291d4ef5a5299b7745a5ec35
institution Directory Open Access Journal
issn 2222-1751
language English
last_indexed 2024-12-11T18:14:58Z
publishDate 2018-09-01
publisher Taylor & Francis Group
record_format Article
series Emerging Microbes and Infections
spelling doaj.art-0bdfa9fd291d4ef5a5299b7745a5ec352022-12-22T00:55:27ZengTaylor & Francis GroupEmerging Microbes and Infections2222-17512018-09-017111010.1038/s41426-018-0154-6A live attenuated vaccine prevents replication and transmission of H7N9 highly pathogenic influenza viruses in mammalsWenyu Yang0Xin Yin1Lizheng Guan2Mei Li3Shujie Ma4Jianzhong Shi5Guohua Deng6Yasuo Suzuki7Hualan Chen8College of Veterinary Medicine, Gansu Agriculture UniversityState Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural SciencesState Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural SciencesState Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural SciencesState Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural SciencesState Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural SciencesState Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural SciencesCollege of Life and Health Sciences, Chubu University, Health Science HillsCollege of Veterinary Medicine, Gansu Agriculture UniversityAbstract H7N9 influenza viruses emerged in 2013 and have caused severe disease and deaths in humans in China. Some H7N9 viruses circulating in chickens have mutated to highly pathogenic viruses that have caused several disease outbreaks in chickens. Studies have shown that when the H7N9 highly pathogenic viruses replicate in ferrets or humans, they easily acquire certain mammalian-adapting mutations and become highly lethal in mice and highly transmissible in ferrets by respiratory droplet, creating the potential for human-to-human transmission. Therefore, the development of effective control measures is a top priority for H7N9 pandemic preparedness. In this study, we evaluated the protective efficacy of a cold-adapted, live attenuated H7N9 vaccine (H7N9/AAca) against two heterologous H7N9 highly pathogenic viruses in mice and guinea pigs. Our results showed that one dose of the H7N9/AAca vaccine prevented disease and death in mice challenged with two different H7N9 highly pathogenic viruses, but did not prevent replication of the challenge viruses; after two doses of H7N9/AAca, the mice were completely protected from challenge with A/chicken/Hunan/S1220/2017(H7N9) virus, and very low viral titers were detected in mice challenged with H7N9 virus CK/SD008-PB2/627 K. More importantly, we found that one dose of H7N9/AAca could efficiently prevent transmission of CK/SD008-PB2/627 K in guinea pigs. Our study suggests that H7N9/AAca has the potential to be an effective H7N9 vaccine and should be evaluated in humans.http://link.springer.com/article/10.1038/s41426-018-0154-6
spellingShingle Wenyu Yang
Xin Yin
Lizheng Guan
Mei Li
Shujie Ma
Jianzhong Shi
Guohua Deng
Yasuo Suzuki
Hualan Chen
A live attenuated vaccine prevents replication and transmission of H7N9 highly pathogenic influenza viruses in mammals
Emerging Microbes and Infections
title A live attenuated vaccine prevents replication and transmission of H7N9 highly pathogenic influenza viruses in mammals
title_full A live attenuated vaccine prevents replication and transmission of H7N9 highly pathogenic influenza viruses in mammals
title_fullStr A live attenuated vaccine prevents replication and transmission of H7N9 highly pathogenic influenza viruses in mammals
title_full_unstemmed A live attenuated vaccine prevents replication and transmission of H7N9 highly pathogenic influenza viruses in mammals
title_short A live attenuated vaccine prevents replication and transmission of H7N9 highly pathogenic influenza viruses in mammals
title_sort live attenuated vaccine prevents replication and transmission of h7n9 highly pathogenic influenza viruses in mammals
url http://link.springer.com/article/10.1038/s41426-018-0154-6
work_keys_str_mv AT wenyuyang aliveattenuatedvaccinepreventsreplicationandtransmissionofh7n9highlypathogenicinfluenzavirusesinmammals
AT xinyin aliveattenuatedvaccinepreventsreplicationandtransmissionofh7n9highlypathogenicinfluenzavirusesinmammals
AT lizhengguan aliveattenuatedvaccinepreventsreplicationandtransmissionofh7n9highlypathogenicinfluenzavirusesinmammals
AT meili aliveattenuatedvaccinepreventsreplicationandtransmissionofh7n9highlypathogenicinfluenzavirusesinmammals
AT shujiema aliveattenuatedvaccinepreventsreplicationandtransmissionofh7n9highlypathogenicinfluenzavirusesinmammals
AT jianzhongshi aliveattenuatedvaccinepreventsreplicationandtransmissionofh7n9highlypathogenicinfluenzavirusesinmammals
AT guohuadeng aliveattenuatedvaccinepreventsreplicationandtransmissionofh7n9highlypathogenicinfluenzavirusesinmammals
AT yasuosuzuki aliveattenuatedvaccinepreventsreplicationandtransmissionofh7n9highlypathogenicinfluenzavirusesinmammals
AT hualanchen aliveattenuatedvaccinepreventsreplicationandtransmissionofh7n9highlypathogenicinfluenzavirusesinmammals
AT wenyuyang liveattenuatedvaccinepreventsreplicationandtransmissionofh7n9highlypathogenicinfluenzavirusesinmammals
AT xinyin liveattenuatedvaccinepreventsreplicationandtransmissionofh7n9highlypathogenicinfluenzavirusesinmammals
AT lizhengguan liveattenuatedvaccinepreventsreplicationandtransmissionofh7n9highlypathogenicinfluenzavirusesinmammals
AT meili liveattenuatedvaccinepreventsreplicationandtransmissionofh7n9highlypathogenicinfluenzavirusesinmammals
AT shujiema liveattenuatedvaccinepreventsreplicationandtransmissionofh7n9highlypathogenicinfluenzavirusesinmammals
AT jianzhongshi liveattenuatedvaccinepreventsreplicationandtransmissionofh7n9highlypathogenicinfluenzavirusesinmammals
AT guohuadeng liveattenuatedvaccinepreventsreplicationandtransmissionofh7n9highlypathogenicinfluenzavirusesinmammals
AT yasuosuzuki liveattenuatedvaccinepreventsreplicationandtransmissionofh7n9highlypathogenicinfluenzavirusesinmammals
AT hualanchen liveattenuatedvaccinepreventsreplicationandtransmissionofh7n9highlypathogenicinfluenzavirusesinmammals